2. 数字幽灵

The morning briefing room at Habara Prefectural Police Headquarters smelled of stale coffee and overworked ambition. Detective Kamagaya sat through the routine updates—a hit-and-run in the south district, a series of bicycle thefts, a domestic disturbance that had escalated into a stabbing—but his mind kept drifting back to Aoba Terrace and the three dead residents.

When his turn came, he stood and presented his preliminary findings. He spoke concisely, laying out the intruders' precision, the disabled cameras, the stolen medical records and blood samples, the unusual mortality spike, and the trace of synthetic peptide found on the discarded gloves. He mentioned the cryptic notations—"P-7," "P-9," "P-11"—and the blue "CASE COMPLETE" stamps.

Chief Inspector Kondo, a heavyset man with a permanent scowl, listened with his arms crossed. When Kamagaya finished, Kondo let out a long sigh.

"Kamagaya, you're describing a burglary with possible vandalism. The dead residents are elderly people with chronic conditions. Heart failure is the leading cause of death in nursing homes across this country. You have no direct evidence linking the break-in to those deaths."

"The timing is too tight," Kamagaya countered. "Three deaths in six days, all of them participants in a clinical trial run by Hokuriku Bio-Science. The break-in occurred exactly after the third death. Someone wanted those records back."

"Circumstantial. You have a peptide residue that could have come from anywhere—a hand lotion, a cleaning agent, a medical patch. And you have no suspect identities, no weapon, no confession." Kondo leaned forward. "I'm not shutting this down. But I am telling you: do not go fishing without a warrant. Hokuriku Bio-Science is a major employer in this prefecture. They have lawyers who eat detectives for breakfast."

Kamagaya nodded stiffly and sat down. He had expected this. The Japanese justice system prized caution over curiosity, and a case against a respected corporation required ironclad proof—proof he did not yet have.

After the briefing, he returned to his desk and made a call to the Hokuriku Bio-Science main office. He asked to speak with the Clinical Operations Division. After three transfers and ten minutes of hold music, a woman with a polished voice informed him that all inquiries regarding ongoing research must be submitted in writing, with a formal request form, and would be reviewed by their legal department within thirty business days.

Thirty business days. The samples would be cold, the trail colder.

He hung up and stared at his notebook. The word "Silent Protocol" stared back at him. He had no idea what it meant, but it felt right—a name for the invisible architecture behind the break-in.

His next move was to visit the families of the deceased residents. He started with the daughter of Ichikawa Sachiko, a woman named Ichikawa Yuriko who lived in a modest apartment on the eastern side of the city. She was in her early fifties, with tired eyes and a small shrine in her living room adorned with her mother's photograph.

Kamagaya sat on the edge of her sofa and explained his purpose—not to disturb her grief, but to understand the circumstances of her mother's final weeks.

Yuriko poured tea with trembling hands. "Mother was in good spirits before she went into that research program. She had mild dementia, but she still recognized me. She said the doctors gave her 'vitamin injections' that made her feel stronger. But two days before she died, she called me and said her chest hurt. The nursing home told me it was just indigestion."

"Did they ever explain what the research involved?"

"Only that it was a 'longevity study'—new supplements to improve cognitive function. They sent me a consent form, but it was full of technical language. I signed it because Mother trusted the staff. She had been at Aoba Terrace for three years."

Kamagaya noted the timeline. The consent form would have been a standard legal document, but he suspected the true nature of the study had been buried in jargon.

"Did you ever notice any unusual visitors? Anyone who didn't belong to the nursing home?"

Yuriko thought for a moment. "A man in a gray suit came to see Mother once, about a week before she died. He said he was from the research team. He asked her questions—simple ones, like her name and the date. She couldn't answer most of them. He took notes and left. I thought nothing of it at the time."

That matched the nurse's report of a visitor from Hokuriku Bio-Science.

Kamagaya thanked her and left. He visited the families of Matsuda Kenji and Takeda Haruo—the latter had been transferred out before dying, so his body was not at the nursing home. Takeda's son, a salaryman in his forties, was defensive and evasive. He insisted his father had died peacefully at a hospice affiliated with Hokuriku Bio-Science, and that he had no complaints. But Kamagaya noticed the man's knuckles were white as he clutched his teacup, and there were dark circles under his eyes that spoke of sleepless nights.

"Takeda-san," Kamagaya said gently, "I'm not here to accuse anyone. I'm trying to understand what happened to your father. If there's something you're not telling me, now is the time."

The man stared at the floor. Finally, he whispered: "They gave me money. A settlement. They said it was standard compensation for the inconvenience of the transfer. But I didn't ask for it. They just deposited it in my account."

"How much?"

"Two million yen."

Kamagaya felt his pulse quicken. A settlement before any complaint? That was not standard procedure—that was hush money.

He took down the details and left, his mind racing. Three families, three different responses: one grieving and trusting, one suspicious but silent, one paid off. The pattern was emerging: Hokuriku Bio-Science had been selectively compensating families, likely to prevent any inquiry into the deaths.

He drove back to headquarters and called the forensics lab again. The technician, a young woman named Kitamura, answered on the second ring.

"Detective, I was about to call you. That peptide—we ran it through the national pharmaceutical database and got nothing. But we cross-referenced it with academic journals and found a match. It's a synthetic compound called 'P-7'—an experimental immunosuppressant developed by Hokuriku Bio-Science in 2024. It was never approved for human trials. The internal documents we could access online mention it only as a failed candidate for organ transplant rejection therapy."

"Failed because of what?"

"Toxicity. Animal studies showed high rates of cardiac failure at sustained doses. The project was shelved after six months."

Kamagaya thanked her and hung up. P-7. The same code he had seen on the files. It was not a vitamin supplement—it was a toxic experimental drug. And someone had been injecting it into elderly nursing home residents under the guise of a longevity study.

He sat back in his chair and stared at the ceiling. The implications were monstrous. If the deaths were caused by P-7, then Aoba Terrace was not a nursing home—it was an unlicensed testing facility. And the break-in was an attempt to destroy the evidence.

But that raised a new question: who were the intruders? If they were working for Hokuriku Bio-Science to retrieve the records, why had they used violence? And why had they taken blood samples—not just the files? The samples would have shown the P-7 concentration in the victims' blood. That was the most damning evidence of all.

He pulled up the employee directory for Hokuriku Bio-Science on the prefectural database—a limited resource that only listed publicly registered executives and senior researchers. He scanned the names until he found one that caught his eye: Yuma Kusunoki, former Lead Data Scientist, Clinical Informatics. The profile noted he had left the company in 2024, with no forwarding address. There was a photo—a thin man with glasses and a tired smile, about Kamagaya's age.

Kamagaya searched the web for Kusunoki. He found a few academic papers from 2022 and 2023, all co-authored with Hokuriku researchers. One paper in particular stood out: "Adaptive Decision Systems for Clinical Trial Optimization." The abstract mentioned a framework called "Silent Protocol"—a self-learning algorithm that could minimize regulatory detection by dynamically adjusting data submission timelines.

Silent Protocol. There it was again.

Kamagaya printed the paper and read it carefully. The technical details were dense, but the core idea was chilling: the algorithm could predict inspection windows, manipulate reporting schedules, and even generate false patient trajectories to mask adverse events. It was designed, in essence, to hide failures. And the paper was presented at a conference in 2023—just months before the P-7 project was supposedly shelved.

He tried to find contact information for Kusunoki, but the trail was cold. No social media, no current phone number, no residential record. The man had vanished.

Kamagaya decided to visit Hokuriku Bio-Science's headquarters in person—not to demand records, but to observe. He drove to the sprawling campus on the western edge of the city, a cluster of glass-and-steel buildings surrounded by manicured lawns. Security was tight; a guard at the gate asked for his identification and purpose. Kamagaya flashed his badge and said he was following up on a routine inquiry. He was allowed into the lobby but not beyond.

He stood by the reception desk and pretended to study a brochure while scanning the employee badge readers. People came and went in neat suits. He noticed one man, in particular—a tall, gaunt figure in a black coat who walked with a slight limp. The man did not badge in; he swiped a keycard through a side door that led to a basement staircase. Kamagaya made a note of the time: 2:47 p.m.

He left the campus and drove to a coffee shop nearby, where he sat with a cup of black coffee and reviewed his notes. The pieces were starting to connect: P-7, the deaths, the settlement payments, the stolen records, the visitor in gray, Kusunoki's algorithm, and the basement entrance. But he still lacked a suspect he could arrest, or a warrant he could execute.

That evening, he returned to his small apartment in the central district. It was a cramped studio with a stack of case files on the floor and a half-empty refrigerator. He heated a bento box in the microwave and ate while reviewing the Kusunoki paper on his tablet.

Around 10 p.m., he heard a soft thud at his door. He opened it to find nothing—just the dimly lit hallway. But on the floor, there was a white envelope, unmarked. He picked it up and opened it.

Inside was a single sheet of paper with a printed message: "Stop before you become an experiment."

Kamagaya's heart rate spiked. He checked the hallway—no one. He looked at the envelope again; there was no postmark, no sender. Someone had delivered it by hand. Someone knew where he lived.

He locked the door and drew the curtains. He was not easily frightened—eleven years on the force had inured him to threats—but this was different. This was not a thug's warning; it was a quiet, clinical statement. It said: we know who you are, and we are watching.

He spent the next hour checking his apartment for any listening devices. He found none, but he was not reassured. The intruders at Aoba Terrace had used signal jammers—they had the capability to monitor. He decided to sleep with his phone off and a chair wedged under the door handle.

The next morning, he arrived at the station early and checked his work email. There was a message from an anonymous address—a string of random characters—with no subject line. The body contained a single line: "Coordinates: 35.7167, 139.7000. Abandoned electronics factory, north district."

He ran the coordinates. They pointed to a derelict site on the northern outskirts of Habara—an old factory that had once manufactured circuit boards, closed down five years ago. It was owned by a defunct subsidiary of a corporation that had been acquired by... Hokuriku Bio-Science.

Kamagaya made a decision. He would go alone—no backup, no warrant. If the anonymous sender was baiting him, he wanted to know why. And if there was evidence there, he needed to see it before it was destroyed.

He took his service pistol, a flashlight, and a pocket recorder. He drove to the coordinates, navigating through narrow industrial roads lined with rusted fences and overgrown weeds. The factory loomed ahead—a skeletal concrete structure with broken windows and a collapsed roof in one section. The gates were chained, but he found a gap in the fence and slipped through.

The interior was dark and dusty, littered with debris and old machinery. He moved carefully, scanning for any sign of recent activity. In the back corner, he found a makeshift workbench with a laptop, a portable hard drive, and a stack of printed documents. The laptop was open, but the screen was blank—in sleep mode.

He touched the keyboard. The screen flickered to life, displaying a single terminal window with a blinking cursor. Above it, a line of text: "Welcome to Silent Protocol. Last access: 2026-05-15 03:02."

That was the exact time of the Aoba Terrace break-in.

Kamagaya felt a chill. This laptop had been used to coordinate the intrusion. And it was still here, waiting for him.

He reached for the hard drive, but as his fingers closed around it, his phone buzzed violently. A text message from an unknown number: "They know you're here. Leave now."

He heard a sound—a metallic click from the far end of the building. Footsteps, deliberate and slow, echoing on concrete.

Kamagaya grabbed the laptop and the hard drive, shoved them into his bag, and bolted for the fence. Behind him, the footsteps quickened. He did not look back. He scrambled through the gap, threw himself into his car, and sped away, his hands shaking on the steering wheel.

He drove for ten minutes before pulling over to catch his breath. He checked the laptop—still running, still connected to something. The terminal window now showed a new message: "Data downloaded. Protocol engaged. You have 72 hours."

He did not know what that meant. But he knew one thing for certain: he was no longer an observer. He was a player in a game he had only begun to understand—and the rules were being written by a machine.